发明名称 |
PHARMACEUTICAL COMBINATIONS |
摘要 |
A pharmaceutical combination comprising (a) a protein kinase C (PKC) inhibitor compound, or a pharmaceutically acceptable salt thereof, and (b) at least one mitogen activated protein kinase (MEK) inhibitor or a pharmaceutically acceptable salt, and optionally a pharmaceutically acceptable carrier, for simultaneous, separate or sequential administration; the uses of such combination in the treatment of proliferative diseases; and methods of treating a subject suffering from a proliferative disease comprising administering a therapeutically effective amount of such combination. |
申请公布号 |
WO2014085381(A1) |
申请公布日期 |
2014.06.05 |
申请号 |
WO2013US71852 |
申请日期 |
2013.11.26 |
申请人 |
NOVARTIS AG;PORTER, DALE;EMERY, CAROLINE;TAN, LUJIAN;YERRAMILLI-RAO, PADMAJA |
发明人 |
PORTER, DALE;EMERY, CAROLINE;TAN, LUJIAN;YERRAMILLI-RAO, PADMAJA |
分类号 |
A61K45/06;A61K31/4184;A61K31/506;A61P35/00 |
主分类号 |
A61K45/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|